BSECompany Update1d ago · 30 Jul 2026, 08:30 pm

Investor Conference call for Q1FY27 - Audio Recording

Mankind Pharma Ltd · 543904

✦ AI SummaryResults

Mankind Pharma Ltd has announced the availability of the audio recording of its Q1FY27 investor conference call, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

c16c6989-c1f9-436d-b506-13c292d2de49.pdf

pdf

Download →
View document text
July 30, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Investor Conference Call for Q1FY27 – Audio Recording Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 17, 2026 under subject ‘Intimation of Investor Conference Call for Q1FY27 with Senior Management of Mankind Pharma Limited (“the Company”)’, the audio recording of the Call held today i.e. July 30, 2026 is available on the website of the Company at: https://www.mankindpharma.com/wp- content/uploads/2026/07/Mankind-Q1-FY27-Audio.mp3. You are requested to kindly take the same on records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer